Zhongzhi Pharmaceutical Holdings Limited provided its monthly return for equity issuers as of 28 February 2026. The company maintained an authorized share capital of 1,560,000,000 ordinary shares at a par value of HKD 0.01 per share, totaling HKD 15.60 million. No changes occurred in authorized share capital or in the issued share quantity, which remained 863.60 million shares.

The report confirms compliance with the applicable public float requirement. No share options, warrants, convertible securities, or other arrangements were recorded during the month.